Business
Retail investors are getting cold feet about stocks, just when the market needs them most
By Katherine Langford
MarketWatch
The excitement around Moderna’s cancer vaccine is cooling. Here’s why.
Marcus Chen
Marcus Chen
Managing Editor · St. Paul, MN
Marcus manages the day-to-day editorial workflow across all brands, coordinating coverage assignments and ensuring editorial standards are met. He previously served as city editor at the Pioneer Press and holds a degree in Political Science from Carleton College.
More from Marcus →Managing Editor · Monday, October 26, 2026 at 1:50 PM · 1 min read
Investors had “incredibly high” expectations around the Phase 3 data for the drugmaker’s experimental cancer treatment.
Up nextRetail investors are getting cold feet about stocks, just when the market needs them mostBusiness · 1 min read
More Health stories
Business
The 5 big voting issues in the midterm elections that will impact your wallet
By Marcus Chen
MarketWatch
Technology
A dot-com survivor warns retail investors against buying the tech dip: ‘You’re taking a knife to a gunfight.’
By Marcus Chen
MarketWatch
Business
Nvidia, AMD and Broadcom could buy Meta shares as part of $35 billion stock offering
By Marcus Chen
MarketWatch